🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial studies the best dose and side effects of siltuximab...
Status
Completed
Location
Emory University Hospital Midtown
Start Date
2020-01-17
Trial ID
NCT04191421
Treatments Being Tested
Summary Currently, the COVID-19 pandemic has overtaken health systems world...
Status
Completed
Location
Adrián Palacios Chavarria
Start Date
2020-10-01
Trial ID
NCT04998253
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of siltuxi...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00402181
Treatments Being Tested
Sepsis is a severe, life-threatening condition caused by an abnormal host r...
Status
Not Yet Recruiting
Location
El Demardash Hospital
Start Date
2026-07-01
Trial ID
NCT07655791
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and effectiveness...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2025-01-07
Trial ID
NCT06737380
Treatments Being Tested
This is an open-label pilot study of tocilizumab (TCZ) 162 mg weekly admini...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2018-11-28
Trial ID
NCT03726749
Treatments Being Tested
This study is a Phase 1 clinical trail to determine the safety, tolerabilit...
Status
Completed
Location
Georgia Health Sciences University
Start Date
2012-09
Trial ID
NCT01696929
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of siltuxima...
Status
Terminated
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00385827
Treatments Being Tested
A multicenter, randomized, double-blind, placebo-controlled, and active dru...
Status
Enrolling By Invitation
Location
Peking University People's Hospital
Start Date
2025-04-09
Trial ID
NCT06726096
Treatments Being Tested
Pathophysiology of polymyalgia rheumatica (PMR) is ill defined. This study ...
Status
Completed
Location
CHRU de Brest
Start Date
2015-01
Trial ID
NCT02888496
Treatments Being Tested